whereas highly and medium-differentiated prostate carcinomata show an average 5 years ' survival rate of 62.5 per cent , this amounts only to 33.9 per cent with the low-differentiated and anaplastic prostate carcinomata .
C0600139
prostate carcinomata
C0033572
prostate